resources
Predicting Bioequivalence During Generic Drug Formulation


Application Notes
Preview - This content has been restricted to logged in users only.
Predict bioequivalence early during generic drug formulation using dissolution and absorption testing to reduce risk, guide excipient selection, and accelerate
Application Notes
This application note explores strategies for predicting bioequivalence early in generic drug formulation. Learn how excipients influence dissolution and absorption, and how integrated in vitro testing can provide more reliable insight into in vivo performance—helping teams reduce risk, guide formulation decisions, and avoid costly late-stage surprises.
